Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Yiran Si"'
Publikováno v:
Cancer Innovation, Vol 2, Iss 5, Pp 376-390 (2023)
Abstract Background Metaplastic breast carcinoma (MBC) is a rare breast cancer subtype; most cases are triple‐negative breast cancers (TNBCs) and are poorly responsive to conventional systemic therapy. Few potential diagnostic and prognostic marker
Externí odkaz:
https://doaj.org/article/98519e4c2703438095e258e497e3c8f8
Publikováno v:
Frontiers in Physiology, Vol 14 (2023)
Ionotropic glutamate receptors (iGluRs), pivotal in mediating excitatory neurosignals within the central nervous system, are instrumental in environmental stress responses. In this investigation, 12 iGluRs identified in the Pacific oyster are herein
Externí odkaz:
https://doaj.org/article/b54140f170874606a49e090860ecf1c5
Autor:
Yimeng Chen, Xue Wang, Feng Du, Jian Yue, Yiran Si, Xiaochen Zhao, Lina Cui, Bei Zhang, Ting Bei, Binghe Xu, Peng Yuan
Publikováno v:
Cancer Biology & Medicine, Vol 20, Iss 2, Pp 155-168 (2023)
Objective: The choice of chemotherapeutic regimen for triple-negative breast cancer (TNBC) remains controversial. Homologous recombination deficiency (HRD) has attracted increasing attention in informing chemotherapy treatment. This study was aimed a
Externí odkaz:
https://doaj.org/article/fd973b336f42493883a24e0714c2307a
Autor:
Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu, Peng Yuan
Publikováno v:
Cancer Biology & Medicine, Vol 18, Iss 3, Pp 849-859 (2021)
Objective: Anlotinib is a novel tyrosine kinase inhibitor blocking angiogenesis. This study was performed to assess the efficacy and safety of anlotinib in patients with metastatic breast cancer. Methods: Patients with HER2-negative breast cancer, wh
Externí odkaz:
https://doaj.org/article/3a298d238d8a49d689459ef39beef0c6
Autor:
Fangchao Zheng, Feng Du, Jiuda Zhao, Xue Wang, Yiran Si, Peng Jin, Haili Qian, Binghe Xu, Peng Yuan
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-15 (2021)
Abstract N6-methyladenosine (m6A) modification is the most prevalent internal mRNA modification and is involved in many biological processes in eukaryotes. Accumulating evidence has demonstrated that m6A may play either a promoting or suppressing rol
Externí odkaz:
https://doaj.org/article/289eb16237a740a78ed3b195c4d6bdd0
Autor:
Fangchao Zheng, Feng Du, Haili Qian, Jiuda Zhao, Xue Wang, Jian Yue, Nanlin Hu, Yiran Si, Binghe Xu, Peng Yuan
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-13 (2021)
Abstract Background N6-methyladenosine(m6A) methylation modification affects the tumorigenesis, progression, and metastasis of breast cancer (BC). However, the expression characteristics and prognostic value of m6A modification in BC are still unclea
Externí odkaz:
https://doaj.org/article/094adf74a5b14688a2a6df3af382bb5a
Autor:
Ting Deng, Haiyang Zhang, Haiou Yang, Huiya Wang, Ming Bai, Wu Sun, Xinyi Wang, Yiran Si, Tao Ning, Le Zhang, Hongli Li, Shaohua Ge, Rui Liu, Dan Lin, Shuang Li, Guoguang Ying, Yi Ba
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 28, Iss , Pp 16- (2022)
Externí odkaz:
https://doaj.org/article/ba53cf0c33e948d28b63003fa96b1692
Autor:
Ting Deng, Haiyang Zhang, Haiou Yang, Huiya Wang, Ming Bai, Wu Sun, Xinyi Wang, Yiran Si, Tao Ning, Le Zhang, Hongli Li, Shaohua Ge, Rui Liu, Dan Lin, Shuang Li, Guoguang Ying, Yi Ba
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 19, Iss , Pp 1449-1459 (2020)
Exosomes, membranous nanovesicles, naturally carry proteins, mRNAs, and microRNAs (miRNAs) and play important roles in tumor pathogenesis. Here we showed that gastric cancer (GC) cell-derived exosomes can function as vehicles to deliver miR-155 to pr
Externí odkaz:
https://doaj.org/article/d10cdd204f964a22be46ddac6b90fa46
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
IntroductionWe performed this clinical trial to evaluate the efficacy and safety of apatinib and oral etoposide in patients with HER2-negative locally advanced or metastatic breast cancer (MBC).MethodsPatients with HER2-negative MBC previously treate
Externí odkaz:
https://doaj.org/article/fdf3294387634e5db007a5c957bf22a1
Publikováno v:
Cellular Physiology and Biochemistry, Vol 51, Iss 6, Pp 2704-2715 (2018)
Background/Aims: Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the second leading cause of cancer-related deaths worldwide. Thus, methods for early diagnosis of CRC are urgently needed. We aimed to identify potential lon
Externí odkaz:
https://doaj.org/article/693ae7f0f5b7483395f23c45ff585ce9